1,844
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

International addiction researchers’ perspectives on the needs of persons with addictions, the use of neuroscientific research for prevention and treatment, and future foci in addictions research

ORCID Icon, ORCID Icon & ORCID Icon
Pages 395-404 | Received 11 Jul 2022, Accepted 06 Mar 2023, Published online: 05 Apr 2023

References

  • Barnett A, Hall W, Fry CL, Dilkes-Frayne E, Carter A. 2018. Drug and alcohol treatment providers’ views about the disease model of addiction and its impact on clinical practice: a systematic review. Drug Alcohol Rev. 37(6):697–720.
  • Barnett Anthony, Fry CL. 2015. The clinical impact of the brain disease model of alcohol and drug addiction: exploring the attitudes of community-based AOD clinicians in Australia. Neuroethics. 8(3):271–282.
  • Bell S, Carter A, Mathews R, Gartner C, Lucke J, Hall W. 2014. Views of addiction neuroscientists and clinicians on the clinical impact of a ‘brain disease model of addiction.’. Neuroethics. 7(1):19–27.
  • Bengtsson M. 2016. How to plan and perform a qualitative study using content analysis. NursingPlus Open. 2:8–14.
  • bepress 2019. Disciplines: digital commons three-tiered taxonomy of academic disciplines. Berkley (USA): Bepress. https://www.bepress.com/reference_guide_dc/disciplines/
  • Blomqvist J, Koski-Jännes A, Cunningham J. 2014. How should substance use problems be handled? Popular views in Sweden, Finland, and Canada. Drugs and Alcohol Today. 14(1):19–30.
  • Braun V, Clarke V. 2006. Using thematic analysis in psychology. Qual Res Psychol. 3(2):77–101.
  • Braun V, Clarke V. 2013. Successful qualitative research: a practical guide for beginners. Los Angeles: SAGE.
  • Clarivate Analytics 2020. InCites. Journal Citation Reports. https://jcr.clarivate.com/JCRLandingPageAction.action?Init=Yes&SrcApp=IC2LS&SID=H2-df99yIL4cJl6UwfMeLJ4aGhm4LxxfYKbxx-18x2dw2WrWm8OCrVTPTpUU0DGKQx3Dx3DfSGlX5b5cUHfUSkbx2BdEkmgx3Dx3D-qBgNuLRjcgZrPm66fhjx2Fmwx3Dx3D-h9tQNJ9Nv4eh45yLvkdX3gx3Dx3D.
  • Creswell JW, Plano Clark VL. 2018. Designing and conducting mixed methods research (Third Edition). Los Angeles (CA): SAGE.
  • Dackis C, O'Brien C. 2005. Neurobiology of addiction: treatment and public policy ramifications. Nat Neurosci. 8(11):1431–1436.
  • Dingel MJ, Hicks AD, Robinson ME, Koenig BA. 2012. Integrating genetic studies of nicotine addiction into public health practice: stakeholder views on challenges, barriers and opportunities. Public Health Genom. 15(1):46–55.
  • Dingel MJ, Karkazis K, Koenig BA. 2012. Framing nicotine addiction as a ‘disease of the brain’: social and ethical consequences. Soc Sci Q. 92(5):1363–1388.
  • Dunbar D, Kushner HI, Vrecko S. 2010. Drugs, addiction and society. BioSocieties. 5(1):2–7.
  • Hall W, Carter A, Forlini C. 2015a. The brain disease model of addiction: is it supported by the evidence and has it delivered on its promises? The Lancet. Psychiatry. 2(1):105–110.
  • Hall W, Carter A, Forlini C. 2015b. Brain disease model of addiction: misplaced priorities? The Lancet. Psychiatry. 2(10):867.
  • Hall W, Carter L, Morley KI. 2003. Addiction, neuroscience and ethics. Addiction. 98(7):867–870.
  • Hammer R, Dingel MJ, Ostergren JE, Nowakowski KE, Koenig BA. 2012. The experience of addiction as told by the addicted: incorporating biological understandings into self-story. Cult Med Psychiatry. 36(4):712–734.
  • Heather N, Best D, Kawalek A, Field M, Lewis M, Rotgers F, Wiers RW, Heim D. 2018. Challenging the brain disease model of addiction: European launch of the addiction theory network. Addict Res & Theory. 26(4):249–255.
  • Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren LJMJ. 2021a. Addiction as a brain disease revised: why it still matters, and the need for consilience. Neuropsychopharmacology. 46(10):1715–1723.
  • Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren LJMJ. 2021b. Response to ‘Addiction is a social disease: just as tenable as calling it a brain disease. Neuropsychopharmacology:. 46(10):1713–1714.
  • Heim D. 2014. Addiction: not just brain malfunction. Nature. 507(7490):40.
  • Hellman M, Egerer M, Stoneham J, Forberger S, Ochterbeck D, Rundle S. 2022. Addiction and the brain: knowledge, beliefs and ethical considerations from a social perspective. Springer Nature, Singapore: Palgrave Macmillan.
  • International Society of Addiction Journal Editors 2020. ISAJE home. London (UK): ISAJE. https://www.isaje.net/.
  • Jack Oller D, Kelly JF, Magidson JF, Wakeman SE. 2019. Asking how our patients understand addiction. Am JlMed. 132(3):269–271.
  • Koski-Jännes A, Hirschovits-Gerz T, Pennonen M. 2012. Population, professional, and client support for different models of managing addictive behaviors. Subst Use Misuse. 47(3):296–308.
  • Kuckartz U. 2018. Qualitative Inhaltsanalyse: methoden, Praxis, Computerunterstützung (4. Auflage). Beltz Juventa.
  • Kuruvilla S, Mays N, Pleasant A, Walt G. 2006. Describing the impact of health research: a research impact framework. BMC Health Serv Res. 6:134.
  • Leshner AI. 1997. Addiction is a brain disease, and it matters. Science. 278(5335):45–47.
  • Mayring P. 2015. Qualitative Inhaltsanalyse: Grundlagen und Techniken (12., überarbeitete Auflage). Weinheim & Basel: Beltz Verlag.
  • Meurk C, Fraser D, Weier M, Lucke J, Carter A, Hall W. 2016. Assessing the place of neurobiological explanations in accounts of a family member’s addiction. Drug Alcohol Rev. 35(4):461–469.
  • Meurk C, Partridge B, Carter A, Hall W, Morphett K, Lucke J. 2014. Public attitudes in Australia towards the claim that addiction is a (brain) disease: is addiction a (brain) disease? Drug Alcohol Rev. 33(3):272–279.
  • Morphett K, Carter A, Hall W, Gartner C. 2017. Framing tobacco dependence as a ‘brain disease’: implications for policy and practice. Nicotine Tob Res. 19(7):774–780.
  • Morphett K, Carter A, Hall W, Lucke J, Partridge B, Gartner C. 2018. Do neurobiological understandings of smoking influence quitting self-efficacy or treatment intentions? Nicotine Tob Res. 20(7):827–835.
  • Mulligan A, Hall L, Raphael E. 2013. Peer review in a changing world: an international study measuring the attitudes of researchers. J Am Soc Inf Sci Technol. 64(1):132–161.
  • National Institute on Drug Abuse (NIDA). 2018. Membership roster NACDA (National Advisory Council on Dug Abuse). https://www.drugabuse.gov/about-nida/advisory-boards-groups/national-advisory-council-drug-abuse-nacda/council-roster.
  • National Institute on Drug Abuse, (NIDA) 2020. Drugs, Brains, and Behavior: The Science of Addiction; Drugs and the Brain. National Institute on Drug Abuse. https://www.drugabuse.gov/publications/drugs-brains-behavior-science-addiction/drugs-brain.
  • National Institutes of Health (NIH). 2018. Membership roster PDMA (Pathophysiological Basis of Mental Disorders and Addictions Study Section Center For Scientific Review). Pathophysiological Basis of Mental Disorders and Addictions Study Section Center For Scientific Review (PDMA): Membership Roster. https://internet.csr.nih.gov/Rosters/MemberRoster.aspx?s=PMDA.
  • Nature E. 2014. Animal farm. Nature. 506(7486):5–5.
  • Neale J, Miller P, West R. 2014. Reporting quantitative information in qualitative research: guidance for authors and reviewers. Addiction. 109(2):175–176.
  • Peele S. 2016. People control their addictions: no matter how much the ‘chronic’ brain disease model of addiction indicates otherwise, we know that people can quit addictions - with special reference to harm reduction and mindfulness. Addict Behav Rep. 4:97–101.
  • Pickard, H., & Ahmed, S. H. (Eds.) 2020. The Routledge handbook of philosophy and science of addiction (First issued in paperback). London (NY): Routledge, Taylor & Francis Group.
  • Rhodes T, Coomber R. 2010. Qualitative methods and theory in addictions research. In P. G. Miller, J. Strang, & P. M. Miller (Eds.), Addiction research methods. (p. 59–78. Oxford (UK): Wiley-Blackwell.
  • Room R. 2021. No level has primacy in what is called addiction: ‘addiction is a social disease’ would be just as tenable. Neuropsychopharmacology 46(10):1712.
  • Seale C. 1999. The quality of qualitative research. London: Sage Publications.
  • Thomas DR. 2006. A general inductive approach for analyzing qualitative evaluation data. Am JEval. 27(2):237–246.
  • Tomlinson M, Rudan I, Saxena S, Swartz L, Tsai AC, Patel V. 2009. Setting priorities for global mental health research. Bull. World Health Organ. 87(6):438–446.
  • Uhl GR, Koob GF, Cable J. 2019. The neurobiology of addiction. Ann N. Y Acad of Sciences. 1451(1):5–28.
  • Volkow ND, Boyle M. 2018. Neuroscience of addiction: relevance to prevention and treatment. Am J Psychiatry. 175(8):729–740.
  • Volkow ND, Koob G. 2015. Brain disease model of addiction: why is it so controversial? The Lancet. Psychiatry. 2(8):677–679.
  • Volkow ND, Koob GF, McLellan AT. 2016. Neurobiologic advances from the brain disease model of Addiction. N Engl J Med. 374(4):363–371.
  • Wiens TK, Walker LJ. 2015. The chronic disease concept of addiction: helpful or harmful? Addict Res Theory. 23(4):309–321.